Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.
We investigated whether platelet-tritiated paroxetine binding, a measure of serotonin uptake sites, and behavioral measures of impulsivity, aggression, and craving differed between cocaine-dependent subjects and controls and whether paroxetine binding was related to these behavioral measures. One hundred and five African-American cocaine-dependent outpatients and 44 African-American controls were studied. Tritiated paroxetine binding sites on platelets were assayed, and standardized assessments of impulsivity, aggression, and craving were performed. The Bmax values of paroxetine binding were significantly reduced among cocaine patients compared to controls. Cocaine patients showed significantly higher scores on certain measures of sensation seeking, impulsivity, and aggression as compared to controls. Furthermore, paroxetine binding showed a significant negative correlation with most measures of sensation seeking, impulsivity, and aggression--though not craving--among cocaine patients. Our findings indicate that densities of serotonin uptake sites may be reduced among cocaine abusers and related to impulsive-aggressive behavioral dimensions.
Patkar
Ashwin A
AA
Division of Substance Abuse Programs, Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, PA 19107, USA. ashwin.patkar@mail.tju.edu
Gottheil
Edward
E
Berrettini
Wade H
WH
Hill
Kevin P
KP
Thornton
Charles C
CC
Weinstein
Stephen P
SP
D000328:Adult; D000374:Aggression / Q000502:physiology* / Q000523:psychology; D000553:Ambulatory Care; D044383:Black People; D001792:Blood Platelets / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism; D019970:Cocaine-Related Disorders / Q000097:blood* / Q000175:diagnosis / Q000534:rehabilitation; D004328:Drive; D005260:Female; D006801:Humans; D007175:Impulsive Behavior / Q000097:blood* / Q000175:diagnosis; D008297:Male; D017374:Paroxetine / Q000493:pharmacokinetics; D010552:Personality Assessment; D015143:Philadelphia; D011869:Radioligand Assay; D011955:Receptors, Drug / Q000378:metabolism; D011985:Receptors, Serotonin / Q000097:blood*; D012016:Reference Values; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000175:diagnosis / Q000534:rehabilitation; D014505:Urban Population; D001741:Black or African American
D002352:Carrier Proteins; D017374:Paroxetine; D011955:Receptors, Drug; D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C092604:paroxetine receptor